Neuroepidemiology

Original Paper

Inter-Rater Reliability of the Diagnosis of Vascular Cognitive Impairment at a Memory Clinic

Wentzel C.a · Darvesh S.a,b · MacKnight C.a · Shea C.c · Rockwood K.a

Author affiliations

Divisions of aGeriatric Medicine and bNeurology, Department of Medicine, and cDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada

Related Articles for ""

Neuroepidemiology 2000;19:186–193

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: June 16, 2000
Issue release date: July – August

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 2

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

Abstract

Consensus criteria for the diagnosis of vascular dementia (VaD) are gradually being replaced with data-based criteria. We report the inter-rater reliability of a new set of empirically-derived criteria for vascular cognitive impairment (VCI). Stratified sampling, with optimal allocation, was employed to randomly select 36 patients from the Queen Elizabeth II Health Science Centre’s Memory Disability Clinic. Chart reviews were conducted independently by 4 physicians. Each physician classified the patients as having either: no cognitive impairment, VCI or Alzheimer’s disease (AD). VCI was further classified both clinically (VCI without dementia, VaD or AD with a vascular component) and radiographically (infarcts, white matter changes, single strategic stroke). The intraclass correlation coefficient (ICC) for the diagnosis by physicians of VCI or otherwise was based on a repeated-measures analysis of variance with raters as the independent variable. A significant coefficient of reliability (average ICC = 0.88, 95% CI = 0.80–0.93) was obtained (Ho: ρ ≤ 0.80, p = 0.03). Where differences in diagnosis occurred, the discrepancies most commonly resulted within the subtypes of VCI (9 cases) or between the diagnoses of AD and VCI (9 cases). Instances of diagnostic incongruity were typically due to the disagreement of a single rater (10 cases). This study demonstrates a high degree of reliability of criteria for VCI by physicians in a memory clinic, and can also be understood as an aspect of construct validation of those criteria. In the absence of a readily available biological marker for VCI, clinical criteria are necessary and can be reliably employed.

© 2000 S. Karger AG, Basel




Related Articles:


References

  1. Hachinski V: Vascular dementia: A radical redefinition. Dementia 1994;5:130–132.
  2. Hachinski VC: The decline and resurgence of vascular dementia. Can Med Assoc J 1990;142:107–111.
  3. Bowler JV, Eliasziw M, Steenhuis R, Munoz DG, Fry R, Merskey H, Hachinski VC: Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol 1997;54:697–703.
  4. Rockwood K, Parhad I, Hachinski V, Erkinjuntti T, Rucastle B, Kertesz A, Phillips S: Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research Consensus Statement. Can J Neurol Sci 1994;21:358–364.
  5. Verhey FRJ, Lodder J, Rozendaal N, Jolles J: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166–172.
  6. Amar K, Wilcock GK, Scott M: The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51–55.
  7. Wetterling T, Kanitz RD, Borgis KJ: Comparison of different diagnostic criteria for vascular dementia: (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30- 36.
  8. Gold G, Giannakopoulos P, Montes-Paixao C, Herrmann FR, Mulligan R, Michel JP, Bouras C: Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690–694.
  9. Hachinski V, Bowler JV: Vascular dementia: Diagnostic criteria for research studies. Neurology 1993;43:2159–2160.
  10. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva, World Health Organization, 1992, pp 25–31.
  11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  12. Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A: Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(suppl 3):S59–S65.
  13. Wallin A: Current definition and classification of dementia diagnosis. Acta Neurol Scand 1996;(suppl 168):39–44.
  14. Rockwood K, Ebly E, Hachinski V, Hogan D: Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997;54:33–39.
  15. Rockwood K, Howard K, MacKnight C, Darvesh S: Spectrum of disease in vascular cognitive impairment. Neuroepidemiology, in press.
  16. Donner A, Eliasziw M: Sample size requirements for reliability studies. Stat Med 1987;6:441–448.
  17. Folstein MF, Folstein SE, McHugh PR: The Mini-Mental State: A practical method of grading the cognitive states of patients for the clinician. J Psychiatry Res 1975;12:189–198.
  18. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:176–186.
  19. Reisberg B: Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653–659.
  20. Reisberg B, Ferris SH: The Brief Cognitive Rating Scale (BCRS). Psychopharmacol Bull 1988;24:629–636.
    External Resources
  21. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136–1139.
  22. Assessing Dementia: The Canadian consensus. Organizing Committee, Canadian Consensus Conference on the Diagnosis of Dementia. Can Med Assoc J 1991;144:851–853.
  23. Tatemichi TK: How acute brain failure becomes chronic: A view of the mechanisms of dementia related to stroke. Neurology 1990;40:1652–1659.
  24. Fleiss JL: Statistical Methods for Rates and Proportions. New York, Wiley & Sons, 1981.
  25. Rockwood K: Lessons from mixed dementia. Int Psychogeriatr 1997;9:245–249.
  26. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793–1796.
  27. Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, Heyman A: Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997;48:668–672.
  28. Thomas VS, Rockwood K, McDowell I: Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol 1998;51:315–321.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: June 16, 2000
Issue release date: July – August

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 2

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP